110 related articles for article (PubMed ID: 25826361)
1. Nucleoside analogs and tuberculosis: new weapons against an old enemy.
Ferrari V; Serpi M
Future Med Chem; 2015; 7(3):291-314. PubMed ID: 25826361
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?
Serpi M; Ferrari V; Pertusati F
J Med Chem; 2016 Dec; 59(23):10343-10382. PubMed ID: 27607900
[TBL] [Abstract][Full Text] [Related]
4. Investigation of 4-amino-5-alkynylpyrimidine-2(1H)-ones as anti-mycobacterial agents.
Garg G; Pande M; Agrawal A; Li J; Kumar R
Bioorg Med Chem; 2016 Apr; 24(8):1771-7. PubMed ID: 26988804
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of acyclic nucleoside phosphonates targeting flavin-dependent thymidylate synthase in Mycobacterium tuberculosis.
Biteau NG; Roy V; Lambry JC; Becker HF; Myllykallio H; Agrofoglio LA
Bioorg Med Chem; 2021 Sep; 46():116351. PubMed ID: 34391120
[TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.
Srivastav NC; Shakya N; Bhavanam S; Agrawal A; Tse C; Desroches N; Kunimoto DY; Kumar R
Bioorg Med Chem Lett; 2012 Jan; 22(2):1091-4. PubMed ID: 22178557
[TBL] [Abstract][Full Text] [Related]
9. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
10. Novel targets in M. tuberculosis: search for new drugs.
Lamichhane G
Trends Mol Med; 2011 Jan; 17(1):25-33. PubMed ID: 21071272
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologically active metabolites, combination screening and target identification-driven drug repositioning in antituberculosis drug discovery.
Kigondu EM; Wasuna A; Warner DF; Chibale K
Bioorg Med Chem; 2014 Aug; 22(16):4453-61. PubMed ID: 24997576
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antimycobacterial evaluation of various 6-substituted pyrazolo[3,4-d]pyrimidine derivatives.
Trivedi A; Vaghasiya S; Dholariya B; Dodiya D; Shah V
J Enzyme Inhib Med Chem; 2010 Dec; 25(6):893-9. PubMed ID: 21054238
[TBL] [Abstract][Full Text] [Related]
13. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
[TBL] [Abstract][Full Text] [Related]
14. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains.
Manvar A; Bavishi A; Radadiya A; Patel J; Vora V; Dodia N; Rawal K; Shah A
Bioorg Med Chem Lett; 2011 Aug; 21(16):4728-31. PubMed ID: 21752642
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth.
Wall MD; Oshin M; Chung GA; Parkhouse T; Gore A; Herreros E; Cox B; Duncan K; Evans B; Everett M; Mendoza A
Bioorg Med Chem Lett; 2007 May; 17(10):2740-4. PubMed ID: 17418567
[TBL] [Abstract][Full Text] [Related]
16. A facile synthesis and antimycobacterial evaluation of novel spiro-pyrido-pyrrolizines and pyrrolidines.
Ranjith Kumar R; Perumal S; Senthilkumar P; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Sep; 44(9):3821-9. PubMed ID: 19524332
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
19. Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase.
Breda A; Machado P; Rosado LA; Souto AA; Santos DS; Basso LA
Eur J Med Chem; 2012 Aug; 54():113-22. PubMed ID: 22608674
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Bacillus anthracis thymidine kinase as a potential target for the development of antibacterial nucleoside analogs.
Carnrot C; Vogel SR; Byun Y; Wang L; Tjarks W; Eriksson S; Phipps AJ
Biol Chem; 2006 Dec; 387(12):1575-81. PubMed ID: 17132103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
